1C | Kruskal–Wallis one-way ANOVA, H = 21.05,p < 0.001 | Dunn; before pulse vs 1:25: Q = 0.73, p > 0.05; before pulse vs 1:5, 1:3, 1:1: Q > 2.5, p < 0.05 |
1G | Unpaired t test, t = −3.27, p = 0.006 for spontaneous firing rate and t = -2.21, p = 0.049 for peak firing rate | |
3E | Two-way ANOVA, F = 6.15, p = 0.003 | Bonferroni vs peripheral voltage; at 1:125, 1:25, 1:10: vs presynaptic voltage and presynaptic Ca2+: t < 1.96, p > 0.09;at 1:5, 1:1: vs presynaptic Ca2+: t < 1.47, p > 0.29; vs presynaptic voltage: t > 3.11, p < 0.005 |
3I | Two-way ANOVA, F = 7.63, p = 0.008 | Bonferroni; at 1:25: t = 0.55, p = 0.59; at 1:5: t = 2.09, p = 0.04; at 1:3: t = 2.24, p = 0.03; at 1:1: t = 0.84, p = 0.41 |
3N | Two-way ANOVA, F = 268.5, p < 0.001 | Bonferroni; at 1:125: t = 0.07, p = 0.95; at 1:25: t = 0.49, p = 0.63; at 1:5: t = 14.85, p < 0.001; at 1:1: t = 17.37, p = 0<0.001 |
4G | Two-way ANOVA for repeated measurements, F = 42.46, p < 0.001 | Bonferroni; for CGP: t = 0.55, p = 0.59; for PTX t = 1.28, p = 0.21; for CGP+PTX 1:5: t = 4.38, p < 0.001; for CGP+PTX 1:3:t = 8.59, p < 0.001; CGP+PTX 1:5 vs 1:3, t = 0.27, p = 1 |
4H | Two-way ANOVA for repeated measurements, F = 20.61, p < 0.001 | Bonferroni; for CGP: t = 0.03, p = 0.98; for PTX t = 1.69, p = 0.1; for CGP+PTX 1:5: t = 3.87, p < 0.001; for CGP+PTX 1:3:t = 4.65, p < 0.001; CGP+PTX 1:5 vs 1:3, t = 3.42, p = 0.008 |
4I | Paired t test, t = -3.61, p = 0.011 for maximum response and t = 2.45, p = 0,049 for sharpness | |
5A | Two-way ANOVA for repeated measurements, F = 32.7, p < 0.001 | Bonferroni vs control; vs GABAB-RNAi: t > 2.81, p < 0.02; vs GABAA-RNAi: t = 1.72, p = 0.26 at 1:25, otherwise t > 3.05,p < 0.008; vs GABAB + GABAA-RNAi: t > 2.93, p < 0.012 |
5B | Two-way ANOVA for repeated measurements, F = 9.91, p < 0.001 | Bonferroni vs control; vs GABAB-RNAi: t < 1.07, p > 0.86; vs GABAA-RNAi: t < 1.13, p > 0.78; vs GABAB + GABAA-RNAi:t = 0.15-0.18, p = 1 at 1:125 and 1:25; t = 2.49, p = 0.04 at 1:5; t = 3.15, p = 0.006 at 1:3; t = 5.12, p < 0.001 at 1:1 |
5D, F, H | Two-way ANOVA for repeated measurements, F > 326.31, p < 0.001 | Bonferroni, control vs GABAA, values given for significant time intervals indicated in figure; at 1:25 t > 3.18, p < 0.004; at 1:5t > 3.09, p < 0.006; at 1:3, t > 2.64, p < 0.025 |
5D | Two-way ANOVA for repeated measurements, F > 326.31, p < 0.001 | Bonferroni, control vs GABAB, values given for significant time intervals indicated in figure; at 1:25 t > 2.52, p < 0.035 |
5F, H, J | Two-way ANOVA for repeated measurements, F > 326.31, p < 0.001 | Bonferroni, control vs GABAA + GABAB values given for significant time intervals indicated in figure; at 1:5 t > 2.56, p < 0.03; at 1:3t > 3.09, p < 0.006; at 1:1 t > 2.74, p < 0.018 |
6G | Two-way ANOVA, F = 26.7, p < 0.001 | Bonferroni vs control; vs GABAA-RNAi, at 1:25 and 1:5 t = 3.56 and t = 3.59, p = 0.001; vs GABAA + GABAB-RNAi (+Dicer), at 1:25:t = 4.72, p < 0.001 (t = 5.11, p < 0.001); at 1:5: t = 2.53, p = 0.046 (t = 5.32, p < 0.001); at 1:1: t = 2.83, p < 0.001 (t = 5.35, p < 0.001) |
6H | Two-way ANOVA, F = 21.7, p < 0.001 | Bonferroni vs control; vs GABAA-RNAi (27E2), at 1:25, t = 3.39 andt = 5.74, p < 0.001; at 1:1 t = 4.51 and t = 5.31, p < 0.001 |
7A | Two-way ANOVA, F = 7.17, p < 0.001 | Bonferroni; differences between distances only significant for 1:1: 0-4 cm vs 4-10 cm, t > 2.98, p < 0.03 |
8C | Two-way ANOVA, F = 12.94, p < 0.001 | Bonferroni vs control; at 0-1 post-pulse time t = 3.49-3.52, p = 0.009-0.002; at 2-3 s post-pulse time, t = 3.15-3.18, p = 0.007; at 3-4 s post-pulse time, t = 3.02, p = 0.01 |
8D | Two-way ANOVA, F = 6.63, p < 0.001 | Bonferroni vs control; at 1-2 s post-pulse time, t = 3.33-3.6, p = 0.003-0.001; at 2-3 s post pulse time, t = 2.52-2.9, p = 0.047-0.015; at 3-4 s post pulse time, t = 3.29, p = 0.004 |